The Latest Cardiac and Vascular News
SINGAPORE, Jan. 7, 2022 /PRNewswire/ — Genesis MedTech Group (Genesis or Group) has appointed Dr. Eitan Konstantino (Eitan) as CTO of Vascular Interventions to propel Genesis’ technology innovation within the neurovascular, cardiovascular and peripheral vascular spaces. His role will include developing and implementing the Group’s global Vascular Interventions R&D strategy, driving the enhancement of […]
Royalty Pharma Extends Capital to Cytokinetics to Support the Commercial Launch of Omecamtiv Mecarbil and the Further Development of Aficamten Royalty Pharma Purchases Royalties on Future Sales of Aficamten Cytokinetics to Host Conference Call and Webcast Today at 8:30 am Eastern Time SOUTH SAN FRANCISCO, Calif. and NEW YORK, Jan. […]
Fiscal 2022 Second Quarter Highlights Net sales of $78.3 million increased 7.6% compared to the prior-year quarter Med Tech growth of 36.4% and Med Device growth of 0.8% year over year Gross margin of 51.8% declined 340 basis points year over year GAAP loss per share of $0.21, and adjusted […]
SAN FRANCISCO and BETHPAGE, N.Y., Jan. 5, 2022 /PRNewswire/ — Housatonic Partners, a growth-oriented private equity firm focused on investing in market-leading services companies, announced a strategic growth investment in Mobile Vascular Physicians (“MVP”), a New York-based concierge medical practice that utilizes a specialized, mobile approach to provide vascular and interventional radiology services to residents […]
CAMBRIDGE, Mass., Jan. 5, 2022 /PRNewswire/ — Anthos Therapeutics, a late-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today announced the appointment of David McIntyre as Chief Financial Officer. Mr. McIntyre will assume responsibility for the company’s finance and investor relation functions, and joins Anthos as its lead product candidate, abelacimab, expects […]
WEST CHESTER, Pa., Jan. 4, 2022 /PRNewswire/ — VESTECK, Inc. is pleased to announce the final closing of their $5.95M Series A financing, which includes conversion of all existing convertible notes. The A round was led by Florida based New World Angels (https://www.newworldangels.com/), followed by DeepWork Capital (https://www.deepworkcapital.com/) and Ocean Azul Partners (https://oceanazulpartners.com/). VESTECK received significant support […]
HOUSTON–(BUSINESS WIRE)–Saranas announces today the closing of the company’s two largest Integrated Delivery Network (IDN) contracts and agreements signed to date: CommonSpirit Health and the Department of Defense. CommonSpirit Health, encompassing all Catholic Health Initiative (CHI) and Dignity Health hospitals, has awarded Saranas a multi-year contract for the use of […]
MORRISVILLE, N.C., Jan. 03, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced Dr. Roger Jeffs has been appointed as Chief Executive Officer (CEO) effective January 3, 2022 and will continue as a director on the board. He succeeds Damian deGoa who will remain a director of the Company […]
– Addition to management team brings experienced strategic legal counsel as Company nears pivotal milestones – ANN ARBOR, Mich., Jan. 04, 2022 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR), today announced the appointment of Benjamin O. Looker as general counsel as of January 1, 2022. Mr. Looker will serve as a […]
DURHAM, N.C., Dec. 31, 2021 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the appointment of Surgical Key Opinion Leaders (KOLs) Alan P. Kypson, M.D., FACS; Luigi Pascarella, M.D., FACS; and Todd E. Rasmussen, M.D., […]
